CD4 and neoplasm: We show that patients with intense CD4+ cell infiltration (>4.6%) or weak CD20+ cell infiltration (<10%), as well as patients with high PD-L1 expression on tumor cells (≥1%), could be characterized by a higher risk of recurrence.